Yazi D. Ke
2 Technology Place
Sydney, NSW 2109, Australia
Sydney, NSW 2109, Australia
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 43 publications
PLP1-Targeting Antisense Oligonucleotides Improve FOXG1 Syndrome Mice.
Journal: International journal of molecular sciences
Published: September 18, 2024
Methyl donor supplementation reduces phospho-Tau, Fyn and demethylated protein phosphatase 2A levels and mitigates learning and motor deficits in a mouse model of tauopathy.
Journal: Neuropathology and applied neurobiology
Published: January 30, 2023
Treatment of epilepsy using a targeted p38γ kinase gene therapy.
Journal: Science advances
Published: December 02, 2022
TDP-43 pathology and functional deficits in wild-type and ALS/FTD mutant cyclin F mouse models.
Journal: Neuropathology and applied neurobiology
Published: October 31, 2022
Understanding In Vitro Pathways to Drug Discovery for TDP-43 Proteinopathies.
Journal: International journal of molecular sciences
Published: October 07, 2022
Recent progress in synthetic self-adjuvanting vaccine development.
Journal: Biomaterials science
Published: June 16, 2022
Loss of LAMP5 interneurons drives neuronal network dysfunction in Alzheimer's disease.
Journal: Acta neuropathologica
Published: March 18, 2022
Pathological manifestation of human endogenous retrovirus K in frontotemporal dementia.
Journal: Communications medicine
Published: January 27, 2022
The Nature of Diamino Linker and Halogen Bonding Define Selectivity of Pyrrolopyrimidine-Based LIMK1 Inhibitors.
Journal: Frontiers in chemistry
Published: September 22, 2021
Last Updated: 09/26/2026